Trulieve Cannabis (TRLV) Current Deferred Revenue (2020 - 2026)

Trulieve Cannabis has reported Current Deferred Revenue for 7 years, with the latest figure at $7.0 million in Q2 2026.

• On a quarterly basis, Current Deferred Revenue fell 15.96% year-over-year to $7.0 million in Q2 2026; TTM through Jun 2026 was $7.0 million, a 15.96% decrease from a year earlier, with the FY2025 full-year figure at $9.6 million, up 19.49% from the prior year.
• Current Deferred Revenue was $7.0 million for Q2 2026 at Trulieve Cannabis, down from $10.0 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $10.0 million in Q1 2026, with the low at $1.3 million in Q4 2023.
• Average Current Deferred Revenue over 5 years is $6.6 million, with a median of $6.6 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue plunged 85.89% in 2023, then jumped 501.35% in 2024.
• Over 5 years, Current Deferred Revenue stood at $9.5 million in 2022, then slumped by 85.89% to $1.3 million in 2023, then surged by 501.35% to $8.0 million in 2024, then rose by 19.49% to $9.6 million in 2025, then slipped by 26.78% to $7.0 million in 2026.
• The last three Current Deferred Revenue figures came in at $7.0 million (Q2 2026), $10.0 million (Q1 2026), and $9.6 million (Q4 2025), per Business Quant data.